ACS Laboratory vs Cayman Chemical
Independent peptide testing versus a manufacturer-issued COA — why researchers, compounding pharmacies, and biotech teams use a dedicated third-party lab for verification.
Side-by-side comparison
| Attribute | ACS Laboratory | Cayman Chemical |
|---|---|---|
| Business model | Independent third-party testing lab (does not sell peptides) | Research-reagent manufacturer & supplier |
| Accreditation | independent | ISO 9001 quality system (manufacturer) |
| Standards | ASTM D8558, contributing to ASTM F49 | In-house release specifications |
| Conflict of interest | None — no product line | Tests peptides they also sell |
| Location | Sun City Center, FL, USA | Ann Arbor, MI, USA |
| HPLC purity | Yes (per-sample third-party) | Yes (batch release only) |
| Mass spectrometry ID | Yes | Yes (batch release only) |
| Endotoxin (LAL) | Yes | Limited |
| Karl Fischer moisture | Yes | Limited |
| Tests peptides from other suppliers | Yes — that is the core service | No |
| Turnaround | 5–7 business days | N/A (ships with product) |
Manufacturer COA vs independent COA
A manufacturer COA — Cayman Chemical, Bachem, GenScript, or any peptide supplier — is a release document created by the entity that made and sold the product. It is generally accurate at the point of manufacture, but it is not independent. For anyone who needs to confirm what actually arrived at their door, or defend that data in an audit, an independent third-party COA is a separate document run by a lab that has no financial interest in the outcome.
Same methods, unbiased operator
ACS uses the same core analytical stack — reversed-phase HPLC and LC-MS — but ships the report as an independent third-party verification with documented method validation. We do not sell peptides, so there is no incentive to under-report impurities.